A significant shift is underway in US healthcare procurement. Following back-to-back supply disruptions in 2023–2024 and new tariff increases that took effect in late 2025, hospital supply chain leaders are actively diversifying away from single-source international suppliers.
According to the Association for Healthcare Resource & Materials Management (AHRMM), 34% of US hospitals added at least one new domestic or near-shore medical supply vendor in the first half of 2026 — up from just 18% in 2023. The shift is most pronounced in high-volume consumable categories: examination gloves, surgical masks, and isolation gowns.
Procurement directors cite three primary drivers: tariff-driven cost increases on Southeast Asian goods (averaging 18% for PPE), port congestion extending import lead times beyond 3 weeks, and post-pandemic policy requirements for hospitals to maintain minimum domestic supply reserves.
For distributors with established domestic inventory, this shift represents a significant opportunity to step in as a resilient supply partner — exactly the role Altovend was built to play.